Abstract
Aim:
To study the metabolism of gambogic acid (GA) and the effects of selective cytochrome P-450 (CYP450) inhibitors on the metabolism of GA in rat liver microsomes in vitro.
Methods:
Rat liver microsomes were used to perform metabolism studies. Various selective CYP450 inhibitors were used to investigate their effects on the metabolism of GA and the principal CYP450 isoform involved in the formation of major metabolite M1 in rat liver microsomes. Types of inhibition in an enzyme kinetics model were used to model the interaction.
Results:
GA was rapidly metabolized to two phase I metabolites, M1 and M2, in rat liver microsomes. M1 and M2 were tentatively presumed to be the hydration metabolite and epoxide metabolite of GA, respectively. α-Naphthoflavone uncompetitively inhibited the formation of M1 while ketoconazole, sulfaphenazole, diethyl dithiocarbamate and quinidine had little or no inhibitory effects on the formation of M1.
Conclusion:
GA is rapidly metabolized in rat liver microsomes and M1 is crucial for the elimination of GA. Cytochrome P-450 1A2 is the major rat CYP involved in the metabolism of GA.
Similar content being viewed by others
Article PDF
References
Zhang HZ, Kasibhatla S, Wang Y, Herich J, Guastella J, Tseng B, et al. Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay. Bioorg Med Chem 2004; 12: 309–17.
Liu W, Guo QL, Li Z, Gu HY . Anticancer effect and apoptosis induction of gambogic acid in human gastric cancer line BGC-823. World J Gastroenterol 2005; 11: 3655–9.
Guo QL, You QD, Wu ZQ, Yuan ST, Zhao L . General gambogic acids inhibited growth of human hepatoma SMMC-7721 cells in vitro and in nude mice. Acta Pharmacol Sin 2004; 25: 769–74.
Wu ZQ, Guo QL, You QD, Zhao L, Gu HY . Gambogic acid inhibits proliferation of human lung carcinoma SPC-A1 cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cells. Biol Pharm Bull 2004; 27: 1769–74.
Zhao L, Guo QL, You QD, Wu ZQ, Gu HY . Gambogic acid induces apoptosis and regulates expression of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cells. Biol Pharm Bull 2004; 27: 998–1003.
Kasibnatla S, Jessen KA, Maliartchouk S, Wang JY, English NM, Drewe J, et al. A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid. Cell Biol 2005; 102: 12095–100.
Liu XQ, Zhao Y, Li D, Qian ZY, Wang GJ . Metabolism and metabolic inhibition of clinipine in human liver microsomes. Acta Pharmacol Sin 2003; 24: 263–8.
Dawson JM, Heatlie PL . Lowry method of protein quantification: evidence for photosensitivity. Anal Biochem 1984; 140: 391–3.
Hao K, Liu XQ, Wang GJ . Pharmacokinetics of gambogic Acid in rats. J China Pharm Univ 2005; 36: 338–41. Chinese.
Nakajima M, Inoue T, Shimada N, Tokudome S, Yamamoto T, Kuroiwa Y . Cytochrome P4502C9 catalyzes indomethacin O-demethylation in human liver microsomes. Drug Metab Dispos 1998; 26: 261–6.
Bjornsson T, Callaghan J, Einolf H, Fischer V, Gan L, Grimm S, et al. The conduct of in vitro and in vivo drug-drug interaction studies: A Pharmaceutical Research and Manufacturers of America (PhRMA) perspective. Drug Metab Dispos 2003; 31: 815–32.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the National High Technology “863” Project (No 2003AA2Z347A), and Jiangsu Key Lab of Drug Metabolism and Pharmacokinetics (No BM2001201).
Rights and permissions
About this article
Cite this article
Liu, Yt., Hao, K., Liu, Xq. et al. Metabolism and metabolic inhibition of gambogic acid in rat liver microsomes. Acta Pharmacol Sin 27, 1253–1258 (2006). https://doi.org/10.1111/j.1745-7254.2006.00369.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2006.00369.x
Keywords
This article is cited by
-
Effect of Gambogenic Acid on Cytochrome P450 1A2, 2B1 and 2E1, and Constitutive Androstane Receptor in Rats
European Journal of Drug Metabolism and Pharmacokinetics (2018)
-
Substrate-dependent modulation of the catalytic activity of CYP3A by erlotinib
Acta Pharmacologica Sinica (2011)